Nexplanon 68 MG implants

Ended Awarded

Contract number
SPE2DR26FGAJ1
Awardee
Awarding agency
Obligated
$17,289

Award facts

Contract value 100% obligated
$17,289.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $17,289.20 delivery order to DMS Pharmaceutical Group Inc. on July 16, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Nexplanon 68 mg implants.

PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide through December 31, 2036. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of August 6, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business.

Quick answers

Who was awarded contract SPE2DR26FGAJ1?

SPE2DR26FGAJ1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 16, 2026.

How much is contract SPE2DR26FGAJ1 worth?

The government has obligated $17,289 on SPE2DR26FGAJ1.

Is contract SPE2DR26FGAJ1 an order under another contract?

Yes. SPE2DR26FGAJ1 is a delivery order under SPE2DR25D9335, an indefinite delivery contract.

Was contract SPE2DR26FGAJ1 competed?

The extent of competition for SPE2DR26FGAJ1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award